SupremeCourt

  • Subscribe to our RSS feed.
  • Twitter
  • StumbleUpon
  • Reddit
  • Facebook
  • Digg

Thursday, January 31, 2013

Patent Office makes public the feedback to the Draft Guidelines for Examination of Biotechnology Patents

Posted on 1:50 AM by Unknown
Image of E.Coli Bacilli from here
In a welcome development, the Controller General has made public the feedback that his office received in response to his call for comments on the Draft Guidelines for Examination of Biotechnology Patents. The feedback can be accessed over here on the website of the IPO. Our earlier post on the topic can be accessed over here. 

Most of the replies were from mainly law firms, specializing in patent prosecution. Responses from these law firms like Anand & Anand and Remfry & Sagar indicate that these firms are clearly not happy with the guidelines proposed by the Patent Office. Other responses are from industry bodies like OPPI, ABLE, CropLife and the most important of them all – Biotechnology Industry Organization (BIO). Predictably, all three organizations are not very keen on the guidelines in their present form. 

Of the India based biotech companies, Amrita Therapeutics did reply. An interesting bit of trivia about this company – one of its scientific advisors is Dr. Ananda Chakrabarty, is THE Chakrabarty from the landmark case of Diamond v. Chakrabarty, which was decided by the U.S. Supreme Court back in 1980. The case held that micro-organisms altered/isolated by man, constituted patentable subject matter under S 101 of American Patent Law. The invention in the case, which was assigned to GE, was a modified bacterium which could be used break down oil and hence could be used to clean up oil spills. 

Perhaps the only institution to whole-heartedly support the guidelines was the National Biological Authority constituted under the Biological Diversity Act, 2002. 

The ball is now in the CG’s court. Will the guidelines be modified or will they be published as they stand?
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Posted in biotech, Patent, Transparency | No comments
Newer Post Older Post Home

0 comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Popular Posts

  • Guest Post: Intermediary liability in defamation cases - Parle, Mouthshut & Visakha cases to clarify the law
    Chaitanya Ramachandran, who has blogged for us previously over here and here , has sent us this excellent guest post analyzing the extent of...
  • IP Research Assistant position at IIT, Madras
    Feroz Ali Khader, MHRD IP Chair at the Indian Institute of Technology (IIT) Madras, is looking for research assistants to work on various is...
  • Guest Post: A Step Forward and a Step Back for the Print Disabled
    We are happy to bring our readers our first guest post entry from our SpicyIP Fellowship applicants. Snigdha Roy, a 3rd year student from G...
  • Open Access: What is it about?
    Aaron Swartz' s recent suicide has sparked discussion all over the internet, with much of it to do with his  strong belief in the moral ...
  • Delhi University Restrained for Alleged Admission of Infringement: True Lies?
    This afternoon, in response to my post announcing a petition relating to the OUP-Delhi University copyright dispute, we were informed that...
  • SPICY IP TIDBIT: IPAB reverts “DARJEELING LOUNGE” matter to Registrar
    Background ITC Limited, the appellant, applied for the mark “DARJEELING LOUNGE” which was advertised on 07.02.2005.  Notice of opposition ...
  • Del HC hits a sixer: The Boundaries of Copyright and Cricket
    Our friends at Medianama have pointed us in the direction of one of the most superbly analysed IP judgments that I have read in a long time...
  • SpicyIP Tidbit: An IP Thriller from an IP lawyer
    In an exciting first for the community of intellectual property lawyers in India, Dr. Kalyan Kankanala has penned a thriller novel based, w...
  • Royal Orchid Hotels scores a crucial trademark victory in its long running battle with the Kamat Group
    In a decision dated 18th June, 2013 a bench of the Intellectual Property Appellate Board (IPAB), has allowed the appeals filed by Royal Orch...
  • Guest Post: The New India Guidelines on Similar Biologics
    The Government of India has recently announced certain guidelines regulating the approval of 'similar biologics' also known as bio-s...

Categories

  • 126 (1)
  • 3(d) (4)
  • 3(f) (1)
  • 3(i) (1)
  • 3(k) (2)
  • Academic Writing (1)
  • access (10)
  • access to food (1)
  • access to health (3)
  • AIA (1)
  • AIDS/HIV (3)
  • Antitrust (2)
  • Bajaj v LML (1)
  • Basmati Row (2)
  • Biological Diversity (5)
  • Biologics (2)
  • biopiracy (4)
  • biotech (7)
  • Bollywood (25)
  • Broadcasters Rights (5)
  • Budget (1)
  • business method patent (2)
  • Call for papers (2)
  • Cipla (2)
  • Comparative Advertising (4)
  • Competition law (8)
  • Compulsory Licensing (27)
  • condonation of delay (1)
  • Conference (4)
  • Constitution (12)
  • Contracts (1)
  • Controller's decisions (8)
  • Copyright (112)
  • Copyright Amendment Bill 2010 (23)
  • copyright board (4)
  • Copyright Exceptions (6)
  • copyright office (1)
  • Copyright Rules (2013) (5)
  • Copyright Societies (9)
  • Counterfeiting (1)
  • creativity (1)
  • Cross Retaliation (1)
  • csir (4)
  • d (1)
  • D.U. Photocopy Case (16)
  • Darjeeling Tea (3)
  • Data Exclusivity (2)
  • Database (1)
  • DCGI (2)
  • decompilation (2)
  • defamation (9)
  • Designs (3)
  • Designs Act (3)
  • Differential Pricing (2)
  • Dilution (1)
  • Disabilities (3)
  • Disability (2)
  • DMCA (2)
  • Doha Declaration (1)
  • Domain Names (2)
  • Draft Policy of the Indian Government (2)
  • DRM (1)
  • Drug Regulation (7)
  • education (12)
  • Enercon (1)
  • Enforcement (1)
  • EU (2)
  • ex parte (2)
  • exhaustion (3)
  • Exhaustion of Rights (2)
  • Fair Dealing (8)
  • Fair Use (11)
  • Federal Circuit (1)
  • Fees (3)
  • FICCI (7)
  • FRAND (2)
  • free trade agreement (3)
  • FTA (3)
  • G.I. Registry (4)
  • gene sequences (3)
  • Generic medicine (4)
  • Geographical Indication (14)
  • Gilead (1)
  • Glenmark (5)
  • Gopika (34)
  • Guest post (11)
  • guidelines (1)
  • GWU-CII (1)
  • Herceptin (1)
  • hot news (3)
  • ICANN (1)
  • incremental innovation (1)
  • independence (1)
  • india (5)
  • Indian Government (1)
  • Indian patent litigation (27)
  • Indian Pharma (35)
  • Injunction (10)
  • Innovation (7)
  • INTA (1)
  • Intermediaries (10)
  • internet (11)
  • Internet Access Providers (IAPs) (5)
  • Internet Censorship (7)
  • IP scholarship (3)
  • IP aware (4)
  • IP Course (3)
  • IP Education (1)
  • IP Policy (11)
  • IP update (4)
  • ip writing competition (1)
  • IPAB (34)
  • ipchair (1)
  • IPO (1)
  • IPRS (5)
  • IT Act (1)
  • Journal (2)
  • judicial independence (3)
  • Jurisdiction (1)
  • Kruttika (4)
  • Legal Education (3)
  • Legal Research Tools (1)
  • Legal Scholarship (2)
  • library (2)
  • Licensing (7)
  • Madhulika (20)
  • mathematical methods (1)
  • Media law (3)
  • medical method (1)
  • Merck (4)
  • mhrd ip chair (1)
  • Microsoft (3)
  • Middle Path (1)
  • Moral Rights (2)
  • Movies (18)
  • musical work (2)
  • nanotechnology (1)
  • Natco (3)
  • natco defamation suit (5)
  • natco vs bayer (4)
  • need for transparency (1)
  • Novartis (8)
  • Novartis patent case in India (11)
  • NPEs (2)
  • nujs (1)
  • NUJS Conference (2)
  • Obituary (1)
  • obviousness (7)
  • Off-Topic (2)
  • online course (4)
  • Open Access (6)
  • Open Source (2)
  • Opposition (3)
  • Parallel Imports (4)
  • Parliament (1)
  • passing off (5)
  • Patent (52)
  • Patent act (10)
  • patent agent (5)
  • patent agent exam (9)
  • patent agent exam qualifications (3)
  • patent infringement (5)
  • Patent Licensing (2)
  • Patent litigation (2)
  • Patent Office (19)
  • patent pool (3)
  • Patent Prosecution (7)
  • Patent rules (2)
  • Patent Strategies (8)
  • Patents (9)
  • pegasus (1)
  • Personality Rights (1)
  • Pfizer (1)
  • Pharma (18)
  • Piracy (5)
  • plagiarism (3)
  • Plant Variety Protection (2)
  • post grant (1)
  • Prashant (2)
  • Preventive Detention (1)
  • Price Control (6)
  • prior publication (1)
  • Privacy (3)
  • Prizes (1)
  • public health (3)
  • Public Interest (4)
  • Publicity Rights (4)
  • Publishing (3)
  • radio (2)
  • Rajiv (18)
  • Rectification Petition (2)
  • Rejection (1)
  • research (3)
  • reverse engineering (2)
  • revocation (4)
  • rip (1)
  • Roche (2)
  • Roche vs Cipla (1)
  • Royalty (2)
  • RTI (2)
  • Scholarship (4)
  • section 16 (1)
  • Section 3(d) (7)
  • section 8 (6)
  • shamnad (11)
  • Shan Kohli (4)
  • Shouvik Kumar Guha (30)
  • Smartphones/Tablets (2)
  • Social Innovation (1)
  • Software (10)
  • software enforcement (3)
  • software patent (3)
  • Special 301 Report (1)
  • Spicy Tidbits (6)
  • spicyip (1)
  • SpicyIP Accolades (1)
  • SpicyIP Announcements (9)
  • SpicyIP Case (1)
  • SpicyIP Cases (3)
  • spicyip commiseration (1)
  • SpicyIP Events (11)
  • SpicyIP Fellowship (5)
  • SpicyIP Guest Series (22)
  • SpicyIP Interview (2)
  • SpicyIP Jobs (4)
  • SpicyIP Jobs/General (2)
  • SpicyIP Review (1)
  • SpicyIP Tidbits (11)
  • SpicyIP Weekly Review (27)
  • Statutory Licensing (1)
  • STI Policy 2013 (4)
  • Sugen (3)
  • Supreme Court of India (5)
  • Swaraj (19)
  • Tarnishment (1)
  • Technology (6)
  • Technology Transfer (5)
  • TKDL (5)
  • TPP (1)
  • trade (4)
  • Trade Secret Protection (1)
  • Trademark (59)
  • Trademark dilution (1)
  • Trademark Registry (9)
  • Traditional Knowledge (7)
  • Transparency (5)
  • treaty (1)
  • trial (1)
  • tribunals (2)
  • TRIPS (11)
  • UK (3)
  • unfair competition (5)
  • UNFCCC (1)
  • Universities Research and Innovation Bill (2)
  • US (1)
  • US Patent Reform (1)
  • US Supreme Court (3)
  • viva (3)
  • WIPO (5)
  • Working a Patent (2)
  • Workshop (4)
  • writ (1)
  • WTO (1)

Blog Archive

  • ▼  2013 (364)
    • ►  September (13)
    • ►  August (41)
    • ►  July (36)
    • ►  June (36)
    • ►  May (32)
    • ►  April (51)
    • ►  March (66)
    • ►  February (40)
    • ▼  January (49)
      • The ‘Emcure model’ of Foreign Investment and Joint...
      • Patent Office makes public the feedback to the Dra...
      • SpicyIP Announcement: Brainstorming Session on Tra...
      • Locus standi and public interest under the GI Act ...
      • Spicy IP Weekly Review: January Weeks 2-3
      • Pirates of the Carribean: Retaliating Against IP
      • Delhi High Court clarifies the notification re pat...
      • Two years of continuing disappointment with the Ma...
      • Announcing the SpicyIP Fellows for 2013 - 2014!
      • Guest Post: Looking at IPR Policy in Climate chang...
      • Part I: Is decompilation of software legal under t...
      • Part II: Is decompilation of software legal under ...
      • Correction: Meerut scissors GI still in applicatio...
      • Guest Post: Graphene - Indian Patent filings disma...
      • Patent Ambush: Big Pharma vs Generics
      • Guest Post: For whom is the Indian IPR Regime?
      • Guest Post: More GI news as Meerut Scissors grante...
      • Guest Post: Taking a look at Online Piracy in India
      • Guest Post: Madurai Malli is granted GI status
      • SpicyIP Events: Workshop on Tools for Researching ...
      • INTA announces Annual Calendar of Events - 2013
      • Guest Post: Why are Business Method Patents being ...
      • Guest Post: Bare Licensing in India
      • Guest post: LAVA aims for 100 Mobile App Patents
      • SpicyIP Events: Patracode announces Workshop on To...
      • Samsung at the Supreme Court: Nationalising Exhaus...
      • Analysing Science, Technology and Innovation Polic...
      • Guest Post: Copyright in Social media - AFP v. Dan...
      • Open Access: What is it about?
      • The political economy of the current round of comp...
      • Guest Post: Examining the recently announced Compu...
      • The S(war)tz Legacy and "Open" Lessons for India
      • SpicyIP Events: Patracode announces Workshop on To...
      • Mark Lynas, former anti-GM food activist embraces ...
      • Rebutting ad hominem Twitter attacks
      • IP ideologies and the Swartz suicide
      • Aaron Swartz, RIP
      • Evading the mandatory royalty sharing provisions o...
      • DIPP to issue CLs for Herceptin, Dastinib & Ixabep...
      • SpicyIP Fellowship reminder
      • Introducing Science, Technology and Innovation Pol...
      • The Royalty Payment Siphon by MNCs - Independent D...
      • Introducing Science, Technology and Innovation pol...
      • SpicyIP Weekly Review: January (2013) Week 1
      • Incentives through Recognition? Nobel Assembly sue...
      • Guest Post: Plain Packaging Laws for Tobacco Products
      • Guest Post: Colours as Non-conventional Trademarks
      • FICCI announces online certificate course on Compe...
      • Guest Post: The Unfair Competition Act, 2011 and i...
  • ►  2012 (131)
    • ►  December (29)
    • ►  November (42)
    • ►  October (50)
    • ►  September (10)
Powered by Blogger.